Automated description from the Alliance of Genome Resources (Release 8.3.0)
Predicted to enable enzyme inhibitor activity. Involved in negative regulation of mitochondrial electron transport, NADH to ubiquinone; negative regulation of reactive oxygen species biosynthetic process; and response to hypoxia. Is active in mitochondrion. Is expressed in several structures, including brain; genitourinary system; heart; integumental system; and nose. Orthologous to human COXFA4L2 (cytochrome c oxidase hypoxia associated subunit FA4L2).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.